Free Trial

Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume

$2.69
-0.19 (-6.60%)
(As of 06/21/2024 ET)

Lexaria Bioscience Short Interest Data

Current Short Interest
205,900 shares
Previous Short Interest
157,500 shares
Change Vs. Previous Month
+30.73%
Dollar Volume Sold Short
$800,951.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
12,890,000 shares
Float Size
12,500,000 shares
Short Percent of Float
1.65%
Today's Trading Volume
159,784 shares
Average Trading Volume
255,950 shares
Today's Volume Vs. Average
62%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lexaria Bioscience ?

Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LEXX Short Interest Over Time

LEXX Days to Cover Over Time

LEXX Percentage of Float Shorted Over Time

Lexaria Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2024205,900 shares $800,951.00 +30.7%1.7%0.5 $3.89
5/15/2024157,500 shares $485,100.00 -38.8%1.4%0.3 $3.08
4/30/2024257,200 shares $794,748.00 -41.0%2.3%0.5 $3.09
4/15/2024435,600 shares $866,844.00 -11.2%3.7%0.9 $1.99
3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63
3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90
2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45
2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36
1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49
1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51
12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25
12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27
11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50
11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34
10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38
10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92
9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00
9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87
8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05
8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11
7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83
7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83
6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73
6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69
5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74
5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72
4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09
4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18
3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72
3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71
2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03
2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97
1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21
1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77
12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46
12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79
11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96
11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41
10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21
10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11
The asset beating inflation by 4x (Ad)

Central Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Retirement Protection Kit, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.

Click here to get your free copy today.
9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45
9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93
8/31/2022334,400 shares $989,824.00 -0.1%6.2%6.2 $2.96
8/15/2022334,600 shares $1.07 million -0.1%6.2%5.6 $3.20
7/31/2022334,900 shares $904,230.00 +15.9%6.2%5.6 $2.70
7/15/2022288,900 shares $826,254.00 -33.7%5.4%3.9 $2.86
6/30/2022435,900 shares $1.30 million +3.7%8.1%0.5 $2.98
6/15/2022420,400 shares $941,696.00 +15.7%7.8%0.5 $2.24
5/31/2022363,500 shares $745,175.00 +34.1%6.8%0.4 $2.05
5/15/2022271,100 shares $555,755.00 -8.8%5.0%0.3 $2.05
4/30/2022297,300 shares $826,494.00 +14.2%5.5%0.3 $2.78
4/15/2022260,400 shares $997,332.00 -2.1%4.8%0.3 $3.83
3/31/2022266,100 shares $878,130.00 -3.8%5.0%4.6 $3.30
3/15/2022276,700 shares $868,838.00 -5.6%5.1%3.5 $3.14
2/28/2022293,100 shares $1.04 million -12.4%5.5%1 $3.55
2/15/2022334,700 shares $1.31 million -11.8%6.2%1.1 $3.90
1/31/2022379,600 shares $1.52 million +15.5%14.0%1.2 $4.00
1/15/2022328,800 shares $1.52 million -7.1%12.1%1.1 $4.61
12/31/2021353,800 shares $1.43 million -13.8%13.3%1.2 $4.03
12/15/2021410,300 shares $1.84 million +26.8%15.4%1.3 $4.49
11/30/2021323,500 shares $1.71 million -9.0%12.2%1.1 $5.30
11/15/2021355,300 shares $2.29 million -1.9%14.8%2.2 $6.44
10/29/2021362,200 shares $2.24 million -3.2%15.1%2.1 $6.19
10/15/2021374,000 shares $2.56 million +10.3%15.6%1.8 $6.84
9/30/2021339,000 shares $2.12 million -5.5%14.1%0.3 $6.26
9/15/2021358,900 shares $2.23 million +22.4%15.0%0.3 $6.21
8/31/2021293,300 shares $1.82 million -5.2%12.2%0.3 $6.22
8/13/2021309,300 shares $1.70 million No Change12.9%0.3 $5.51

LEXX Short Interest - Frequently Asked Questions

What is Lexaria Bioscience's current short interest?

Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 205,900 shares of LEXX short. 1.65% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest.

What is a good short interest percentage for Lexaria Bioscience?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.65% of Lexaria Bioscience's floating shares are currently sold short.

Is Lexaria Bioscience's short interest increasing or decreasing?

Lexaria Bioscience saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 205,900 shares, an increase of 30.7% from the previous total of 157,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lexaria Bioscience's float size?

Lexaria Bioscience currently has issued a total of 12,890,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 12,500,000 shares.

How does Lexaria Bioscience's short interest compare to its competitors?

1.65% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lexaria Bioscience: Context Therapeutics Inc. (2.01%), Puma Biotechnology, Inc. (7.12%), Lifecore Biomedical, Inc. (7.19%), Galectin Therapeutics Inc. (8.96%), scPharmaceuticals Inc. (22.09%), I-Mab (1.52%), Syros Pharmaceuticals, Inc. (6.64%), Inventiva S.A. (0.13%), Atossa Therapeutics, Inc. (8.92%), ProQR Therapeutics (0.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Lexaria Bioscience stock?

Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXX shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lexaria Bioscience?

A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further.

How often is Lexaria Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LEXX) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners